Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The development of plasma pseudotargeted GC-MS metabolic profiling and its application in bladder cancer
Yang Zhou, Ruixiang Song, Zhensheng Zhang, et al.
Analytical and Bioanalytical Chemistry (2016) Vol. 408, Iss. 24, pp. 6741-6749
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Development of a plasma pseudotargeted metabolomics method based on ultra-high-performance liquid chromatography–mass spectrometry
Fujian Zheng, Xinjie Zhao, Zhongda Zeng, et al.
Nature Protocols (2020) Vol. 15, Iss. 8, pp. 2519-2537
Closed Access | Times Cited: 191
Current and future perspectives of functional metabolomics in disease studies–A review
Min Yan, Guowang Xu
Analytica Chimica Acta (2018) Vol. 1037, pp. 41-54
Closed Access | Times Cited: 94
A review of validated biomarkers obtained through metabolomics
Ángeles López-López, Ángeles López‐Gonzálvez, Tomás Clive Barker‐Tejeda, et al.
Expert Review of Molecular Diagnostics (2018) Vol. 18, Iss. 6, pp. 557-575
Closed Access | Times Cited: 84
Glutathione peroxidase 4‐dependent glutathione high‐consumption drives acquired platinum chemoresistance in lung cancer‐derived brain metastasis
Wenwen Liu, Yang Zhou, Wenzhe Duan, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 9
Open Access | Times Cited: 69
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer
Nicola Antonio di Meo, Davide Loizzo, Savio Domenico Pandolfo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4173-4173
Open Access | Times Cited: 52
Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis
Wenzhe Duan, Wenwen Liu, Shengkai Xia, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 36
LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma
Xiang Liu, Mingxin Zhang, Xiangming Cheng, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 51
Metabolomic and elemental profiling of blood serum in bladder cancer
Krzysztof Ossoliński, Tomasz Ruman, Valérie Copié, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 12, Iss. 6, pp. 889-900
Open Access | Times Cited: 30
Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method
Yang Zhou, Ruixiang Song, Chong Ma, et al.
Oncotarget (2017) Vol. 8, Iss. 13, pp. 20719-20728
Open Access | Times Cited: 58
Unmasking the Metabolite Signature of Bladder Cancer: A Systematic Review
Francisca Pereira, M. Rosário M. Domingues, Rui Vitorino, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3347-3347
Open Access | Times Cited: 6
Ion-Pair Selection Method for Pseudotargeted Metabolomics Based on SWATH MS Acquisition and Its Application in Differential Metabolite Discovery of Type 2 Diabetes
Lichao Wang, Benzhe Su, Zhongda Zeng, et al.
Analytical Chemistry (2018) Vol. 90, Iss. 19, pp. 11401-11408
Open Access | Times Cited: 39
Serum Metabolomics Study of Nonsmoking Female Patients with Non-Small Cell Lung Cancer Using Gas Chromatography–Mass Spectrometry
Ying Mu, Yang Zhou, Yanfeng Wang, et al.
Journal of Proteome Research (2019) Vol. 18, Iss. 5, pp. 2175-2184
Closed Access | Times Cited: 39
Recent advances in the metabolomic study of bladder cancer
Chandra Sekhar Amara, Venkatrao Vantaku, Yair Lotan, et al.
Expert Review of Proteomics (2019) Vol. 16, Iss. 4, pp. 315-324
Open Access | Times Cited: 36
The application of pseudotargeted metabolomics method for fruit juices discrimination
Lei Xu, Zhenzhen Xu, Xue Wang, et al.
Food Chemistry (2020) Vol. 316, pp. 126278-126278
Closed Access | Times Cited: 31
Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry
Su Zhang, Xin Lü, Chunxiu Hu, et al.
ACS Omega (2020) Vol. 5, Iss. 41, pp. 26402-26412
Open Access | Times Cited: 28
Targeting Metabolic Reprogramming in Bladder Cancer Immunotherapy: A Precision Medicine Approach
Fuyang Liu, Kai Li, Qingyi Zhu
Biomedicines (2025) Vol. 13, Iss. 5, pp. 1145-1145
Open Access
Integration of Proteomics and Metabolomics Revealed Metabolite–Protein Networks in ACTH-Secreting Pituitary Adenoma
Jie Feng, Qi Zhang, Yang Zhou, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 32
Metabolomics for the diagnosis of bladder cancer: A systematic review
Herney Andrés García‐Perdomo, Angélica María Dávila‐Raigoza, Fernando Korkes
Asian journal of urology (2023) Vol. 11, Iss. 2, pp. 221-241
Open Access | Times Cited: 9
Discovering Biomarkers in Bladder Cancer by Metabolomics
Wentao Zhang, Ziwei Zhang, Yadong Guo, et al.
Biomarkers in Medicine (2018) Vol. 12, Iss. 12, pp. 1347-1359
Closed Access | Times Cited: 26
Switching from Fatty Acid Oxidation to Glycolysis Improves the Outcome of Acute‐On‐Chronic Liver Failure
Zujiang Yu, Jingjing Li, Zhigang Ren, et al.
Advanced Science (2020) Vol. 7, Iss. 7
Open Access | Times Cited: 21
LC–MS metabolomics of urine reveals distinct profiles for non-muscle-invasive and muscle-invasive bladder cancer
Júlia Oto, Álvaro Fernández‐Pardo, Marta Roca, et al.
World Journal of Urology (2022) Vol. 40, Iss. 10, pp. 2387-2398
Closed Access | Times Cited: 12
A Serum Metabolomic Signature for the Detection and Grading of Bladder Cancer
Jacopo Troisi, Angelo Colucci, Pierpaolo Cavallo, et al.
Applied Sciences (2021) Vol. 11, Iss. 6, pp. 2835-2835
Open Access | Times Cited: 15
Biomarkers of Metabolomics in Inflammatory Bowel Disease and Damp-Heat Syndrome: A Preliminary Study
Xingxing Wu, Kexin Liu, Qi Wu, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 11
Untargeted ultra-high-resolution mass spectrometry metabolomic profiling of blood serum in bladder cancer
Joanna Nizioł, Krzysztof Ossoliński, Aneta Płaza‐Altamer, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Serum Metabolomics Study of Gliclazide-Modified-Release-Treated Type 2 Diabetes Mellitus Patients Using a Gas Chromatography–Mass Spectrometry Method
Yang Zhou, Cheng Hu, Xinjie Zhao, et al.
Journal of Proteome Research (2018) Vol. 17, Iss. 4, pp. 1575-1585
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top